Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate Change

2nd May 2008 11:30

Tate & Lyle Board Changes Tate & Lyle PLC (the "Company") announces that Stanley Musesengwa, ChiefExecutive International and Stuart Strathdee, Corporate Development Director,will retire from Tate & Lyle's Board of Directors at the Company's Annual General Meeting ("AGM")on 23 July 2008. Stanley Musesengwa has worked for Tate & Lyle for over 28 years and has servedon the Board since April 2003. The Group's portfolio of businesses has beensignificantly reshaped into four Divisions during the past two years and, asexpected, this process has led to Stanley's current position being phased out.As a result, it has been agreed with Stanley that he will stand down from theBoard of Directors and leave Tate & Lyle at the AGM on 23 July 2008 to developfurther his portfolio of interests. In the period from now until the AGM in July, Stanley Musesengwa will assist inan orderly transition of his responsibilities. Direct reporting lineresponsibilities for Tate & Lyle's Sugars, Sucralose and Food & IndustrialIngredients, Europe Divisions will transfer to the Chief Executive from 1 July2008. Stuart Strathdee has worked for Tate & Lyle for over 31 years and has served onthe Board since November 1994. He was appointed to his current position asCorporate Development Director in July 2003. After he stands down as a Directorat the AGM, he will remain with Tate & Lyle for a further year to assist theCompany with its strategic development before he retires at the end of July2009. Sir David Lees, Chairman of Tate & Lyle, said: "Stanley Musesengwa has made anenormous impact on Tate & Lyle. As Chief Operating Officer he led the Company'soperations with great skill during a time of significant change for the businessand in the past two years he has played a key role in developing andimplementing our streamlined organisational structure. I would like to thank himfor all he has done for Tate & Lyle and wish him every success in the future. "Stuart Strathdee has been a key member of the executive team for a number ofyears and has played a major role in driving the strategic direction of thebusiness. The Board is deeply appreciative of Stuart's loyal service as aDirector over the past 14 years and is delighted that Tate & Lyle will continueto benefit from his considerable knowledge and expertise for a further yearafter he stands down from the Board." Stanley Musesengwa said: "I have thoroughly enjoyed my time at Tate & Lyle andit has given me great satisfaction to be part of its development. I wish IainFerguson and his team every success in the future as they continue to drive thebusiness forward." END \* TFor more information contact Tate & Lyle PLC: Ferne Hudson, Head of Media and Public RelationsTel: 020 7626 6525 or Mobile 07713 067433 Tim Lodge, Director of Investor RelationsTel: 020 7626 6525 or Mobile: 07798 837317\* T Note to Editor \* T1. Stanley Musesengwa's current portfolio of interests includes serving as a Non-Executive Director of Croda International plc and as a Trustee of the Eastside Young Leaders Academy.\* T About Tate & Lyle: Tate & Lyle is a world leading manufacturer of renewable food and industrialingredients. It uses innovative technology to transform corn and sugar intovalue-added ingredients for customers in the food, beverage, pharmaceutical,cosmetic, paper, packaging and building industries. The Company is a leader incereal sweeteners and starches, sugar refining, value added food and industrialingredients, and citric acid. Tate & Lyle is the world number-one in industrialstarches and is the sole manufacturer of SPLENDA(R) Sucralose. Headquartered in London, Tate & Lyle is listed on the London Stock Exchangeunder the symbol TATE.L. In the US its ADRs trade under TATYY. The Companyoperates more than 50 production facilities throughout Europe, the Americas andSouth East Asia. In the year to 31 March 2007, it employed 6,900 people in itssubsidiaries with a further 2,300 employed in joint ventures. Sales in the yearto 31 March 2007 totalled £4.0 billion. Additional information can be found onhttp://www.tateandlyle.com. SPLENDA(R) is a trademark of McNeil Nutritionals, LLC Copyright Business Wire 2008

Related Shares:

Tate & Lyle
FTSE 100 Latest
Value8,054.98
Change-419.76